type 2 diabetes
Conditions
Interventions
We use insulin Degludec and insulin Aspart based on an algorithm during length of stay (approximately around 2 weeks) .
Sponsors
Department of Diabetes and Endocrinology, Kansai Rosai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The hospitalized patient because of poor blood sugar and was judged when basal-bolus insulin treatment was necessary
Exclusion criteria
Exclusion criteria: 1)The patient that an agreement to participate in this examination is not provided 2)The patient who needs emergency for treatment including the diabetic ketoacidosis 3)The patient whom diabetic retinopathy is unstable 4)The patient who uses insulin from before hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The days before fasting blood glucose achieving aim blood sugar level (126 mg/dl or less), ratio less than 70 mg/dl of sensor glucose levels, hypoglycemia frequency. | — |
Secondary
| Measure | Time frame |
|---|---|
| The hospitalization days, ratio of before less than 70-140 mg/dl of sensor glucose levels in the discharge day , correlation with the main end-point and patient background | — |
Countries
Japan
Contacts
Public ContactShuhei Nishina
Kansai Rosai Hospital Department of Diabetes and Endocrinology
Outcome results
None listed